CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...

Palisade Bio appoints Dr. Emil Chuang to its Board of Directors, enhancing clinical strategy for Crohn's Disease and Ulcerative Colitis.

Tract Bio, a biotechnology company discovering and developing novel therapies for cancer and inflammatory disease, today announced the appointment of Chris Galloway, M.D., as Chief Medical and ...

CARLSBAD, California - Palisade Bio, Inc. (NASDAQ:PALI), a clinical-stage biopharmaceutical company focused on autoimmune, inflammatory, and fibrotic diseases, announced Wednesday the appointment of ...

A California federal court gave preliminary approval to a settlement to resolve shareholder allegations that ImmunityBio Inc.

Winners of the 2025 Heritage Awards include a 1925 house once owned by the first president of the University of Redlands.

A new study finds evidence of a link between exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) — also known as ...

OncoZenge Provides Market and Strategy UpdateOncoZenge AB (publ) (“OncoZenge” or “the Company”) today announced a comprehensive market and strategy update after successfully securing full funding for ...

Réseau Compassion Network — a francophone organization that’s responsible for a family of health, social, and human service agencies in Manitoba — is celebrating its 25th anniversary this year.

OncoZenge AB (publ) ("OncoZenge" or "the Company") today announced a comprehensive market and strategy update after successfully securing full funding for its BupiZenge Phase 3 clinical trial aimed at ...

Now, inspired by Gibson, others with Parkinson’s and the team at the foundation, Annear has set his sights on a bigger target ...

The proposed resolution comes about two months after the State of Hawaiʻi Board of Land and Natural Resources rejected the ...